Visiting Scientist
at Maven Clinic

If you’d like to hear more about this opportunity or have any questions contact Natalie Henrich, Senior Director of Research Strategy at Maven at

Apply today
HLTH hero image

Visiting Scientist Position

The Visiting Scientist program invites academic and clinical experts to accelerate Maven's clinical research roadmap and drive key innovations within its unique care model for women's and family health. The scientists will cross-functionally collaborate with Maven’s clinical team to work on high priority research projects and bring additional rigor to our care design.

The Maven Visiting Scientist takes a leadership role in bringing a scientific approach to understanding the potential of digital health for women and families, and providing strategic input into Maven’s care design. Priority research areas for 2024 are fertility and menopause, including their intersection with health disparities and social determinants of health. Across all topics, emphasis will be placed on understanding the mechanisms by which a virtual platform impacts members’ experiences and outcomes and to generate insights that are relevant for both Maven and more broadly in care models. As a visiting scientist, you have the opportunity to develop your own research agenda relevant to Maven and to work on projects that are part of the existing research agenda.

The Visiting Scientist works with Maven part-time for up to one year, and receives funding from Maven to protect their academic time.

Apply today

Who we are

Maven is the largest virtual clinic for women's and family health, offering continuous, holistic care for fertility and family building through maternity, parenting, pediatrics and menopause. Maven's award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better maternal health outcomes, as well as enhance DE&I in benefits programs. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company's #1 Most Innovative Health Company and has 15 million lives under management. Maven has raised $300 million in funding from leading investors including General Catalyst, Sequoia, Oak HC/FT, Dragoneer Investment Group and Lux Capital.

Learn more

Maven Visiting Scientists

Prior Visiting Scientist

Dr. Alex Peahl, MD, MSc was Maven’s first Visiting Scientist. Dr. Peahl is an Assistant Professor and physician-investigator in the Department of Obstetrics and Gynecology at the University of Michigan, and a nationally recognized expert on prenatal care redesign and innovation. Dr. Peahl has led some of the most influential research on redesigning prenatal care, including a recent study of the impact of COVID-19 on the evolution of prenatal care delivery guidelines in the United States.

“I have found that right-sizing prenatal care is critical to improve the effectiveness, efficiency, and equity of prenatal care for all patients, particularly for those facing the greatest barriers to care. As a Visiting Scientist, I am excited to share my insights with Maven and collaborate with its clinical team to further advance the company's care model, designing and studying new high-value, patient-centered approaches to maternity care delivery,” said Dr. Peahl.

“Working at Maven has been a wonderful experience. I’ve had the opportunity to lead research, first author publications, and present the findings at conferences. I’ve also helped develop enhanced care plans, increased my knowledge of virtual care, and expanded my professional network.”

Learn more

Current Visiting Scientist

Maven has welcomed a new clinician innovator, Dr. Constance Guille, Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at Medical University of South Carolina, as its second Visiting Scientist. In this role, Dr. Guille brings her expertise as a reproductive psychiatrist to help advance Maven’s clinical research roadmap and provide strategic input on care model design, with a focus on mental health. 

“Having seen the devastating effects of unrecognized and untreated maternal mental health disorders, I believe there is a tremendous need and promise for using digital health to integrate patient-centered maternal behavioral health treatment into routine prenatal care,” said Dr. Guille.

“I am excited to share my insights with Maven to further advance the company's maternal mental health care model.” 

Learn more

Let's deliver exceptional
healthcare together

We’re building something new, because better care can’t wait.

Apply today